Lataa...
An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
This case suggests that initiation of HCV therapy immediately after liver transplantation with well‐tolerated, all‐oral regimens may achieve a virologic cure in HCV‐positive recipients, thus preventing post‐transplant HCV recurrence and associated disease progression. This strategy may broaden utili...
Tallennettuna:
| Julkaisussa: | Clin Case Rep |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378822/ https://ncbi.nlm.nih.gov/pubmed/28396749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.841 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|